Xenazine OverviewTetrabenazine is a drug for the symptomatic treatment of hyperkinetic movement disorders. It is marketed under the trade names Nitoman in Canada and Xenazine in New Zealand, some parts of Europe, and in the United States as an orphan drug and in Iran as Xentra. On August 15, 2008, the U.S. Food and Drug Administration approved the use of tetrabenazine to treat chorea associated with Huntington's disease. Although other drugs had been used "off label," tetrabenazine was the first approved trea...
Read more Xenazine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tetrabenazine
Recent Xenazine Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 12.5mg, 25mg
NDC Database Records for Xenazine: (2 results)Sorted by National Drug Code
- 67386-421 Xenazine 12.5 mg Oral Tablet by Lundbeck Inc.
- 67386-422 Xenazine 25 mg Oral Tablet by Lundbeck Inc.